Lowenstein Sandler represented Inrad Optics, Inc. in the transaction. Inrad Optics, Inc. (OTCMKTS:INRD) a provider of advanced optical components, assemblies and systems, announced its definitive merger...
Luxium Solutions’ $19 Million Acquisition of Inrad Optics
First Wave BioPharma’s Acquisition of ImmunogenX
Lowenstein represented First Wave BioPharma, Inc. in the transaction. First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic...
DarioHealth’s Acquisition of Twill
Lowenstein Sandler represented Twill, Inc. in the transaction. DarioHealth Corp. (NASDAQ: DRIO) executed the acquisition of Twill, Inc., a leader in digital-led care. The combination enables Dario...
Phreesia’s Acquisition of Access eForms
Lowenstein Sandler represented Phreesia in the transaction. Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, announced the acquisition of Access eForms, an...
Celularity’s $150 Million At-the-Market Offering
Lowenstein represented BTIG, LLC, Oppenheimer & Co. Inc., and B. Riley Securities, Inc. as sales agents in the offering. Celularity, Inc. executed an at-the-market offering of up...